Argos Therapeutics (ARGS) Misses Q2 EPS by 5c

August 10, 2016 4:24 PM EDT
Get Alerts ARGS Hot Sheet
Trade ARGS Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Argos Therapeutics (NASDAQ: ARGS) reported Q2 EPS of ($0.48), $0.05 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $488.64 thousand versus the consensus estimate of $200 thousand.

For earnings history and earnings-related data on Argos Therapeutics (ARGS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment